Fruitful Registry
Home › Reference
DrugRadar icon

DrugRadar

Bernhard Franz Georg Gansbacher
FDA & EMA drug approvals
Open in App Store ↗
PG flag PG
AFen-GBAGen-GBAIen-GBBBen-GBBFen-GBBGen-GBBJen-GBBYen-GBCAen-CACDen-GBCGen-GBCIfr-FRCMfr-FRCOes-MXCVen-GBEEen-GBEGen-GBGAfr-FRGBen-GBGHen-GBGRen-GBHNes-MXHRen-GBIEen-GBJOen-GBKYen-GBLBen-GBLRen-GBLVen-GBLYen-GBMMen-GBMNen-GBMWen-GBMXes-MXNGen-GBNPen-GBNZen-AUOMen-GBPAes-MXPEes-MXPGen-GBPKen-GBPYes-MXRUruRWen-GBSBen-GBSCen-GBSEsvSIen-GBSNen-GBSZen-GBTOen-GBTZen-GBUAen-GBUGen-GBUSen-USUYen-GBVGen-GBYEen-GBZMen-GBZWen-GB
61 of 61 storefronts
Content in en-US
Age Rating
12+
Years
Developer
Bernhard Franz Georg Gansbacher
Language
EN
Size
156
MB

Information

Apple ID6784735764
Bundle IDcom.berndgansbacher.pharmatrack
SellerSeller
Min iOS15.0
Min macOS12.0
Device familiesiphone, ipad, ipod
Released2026-07-06
Copyright© 2026 Bernd Gansbacher
WebsiteLink ↗
Privacy policyLink ↗

Icon history 2 versions

current iconCurrent
←
previous iconPrevious

Preview 2 platforms

iPhone 7 images

iPhone screenshot
1 older version
previous version
iPhone screenshot
1 older version
previous version
iPhone screenshot
1 older version
previous version
iPhone screenshot
1 older version
previous version
iPhone screenshot
1 older version
previous version
iPhone screenshot
1 older version
previous version
iPhone screenshot
1 older version
previous version

iPad 6 images

iPad screenshot
1 older version
previous version
iPad screenshot
1 older version
previous version
iPad screenshot
1 older version
previous version
iPad screenshot
1 older version
previous version
iPad screenshot
iPad screenshot

What’s New Version 1.2.1

Compare a whole drug class at once. Search a disease - like CML - and compare all its treatments side by side (for example, the six CML tyrosine kinase inhibitors), each with its FDA and EMA approval dates, drug class, and indication. Plus the latest FDA and EMA approvals, including newly added cell & gene therapies.

Description

DrugRadar is a clean, fast tracker for newly approved pharmaceutical drugs and late-stage clinical trials, built on official public regulatory data. WHAT YOU CAN TRACK • Recent FDA drug approvals with Marketing Authorization dates • EMA (European) approvals and estimated EC decision dates • CDER novel new-drug approvals • Upcoming PDUFA action dates • Critical medicines and late-stage clinical trials (ClinicalTrials.gov) WHY DRUGRADAR • Sourced from official public data: openFDA, EMA, and ClinicalTrials.gov • No account, no ads, no tracking — your data stays on your device • Fast, focused, and easy to scan DrugRadar presents public regulatory information for general informational purposes only. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. DrugRadar is an independent project and is not affiliated with or endorsed by the FDA, EMA, or the U.S. National Library of Medicine.

Accessibility

ipadiphonemacrealityDevicetvoswatch

Version history 5 versions

Build 888154879v1.3.02026-07-11 22:52:42
Compare a whole drug class at once. Search a disease - like CML - and compare all its treatments side by side (for example, the six CML tyrosine kinase inhibitors), each with its FDA and EMA approval dates, drug class, and indication. Plus the latest FDA and EMA approvals, including newly added cell & gene therapies.
Build 888052137v1.2.22026-07-09 15:52:36
• Fixed: some recently authorised EU medicines were missing from the Europe list (e.g. seladelpar/Lyvdelzi for PBC, zuranolone/Zurzuvae) • New: "Back to drug" button when jumping from a medicine to its Phase 3 trials • Fixed: view now scrolls to the top when switching tabs • Smoother scrolling when opening and closing a medicine's detail sheet • The information-only disclaimer is now re-confirmed every 30 days • Updated in-app feature tour, including how often the data refreshes
Build 887942338v1.2.12026-07-07 23:15:11
Corrected wording in the Europe tab: medicines in the "Expected" list are now described as awaiting the European Commission decision, without implying the outcome of the CHMP opinion. The decision date shown remains an estimate.
Build 887913620v1.22026-07-07 05:42:51
NEW IN 1.2 • Home-screen widget — see the next expected EU decisions for the conditions you follow, at a glance. • Add to Calendar — export estimated EU decision dates as calendar events, with a reminder three days ahead. • Saved searches — bookmark any search and re-run it with one tap, separately on each tab. • Find drugs from your home screen — every EU medicine is now in iOS system search, jumping straight to its detail page. • New quick tour — "What you can do here" walks you through every feature (? button in the header). • Fixes and refinements throughout. Estimated dates remain estimates — always verify against official sources. For information only; not medical advice.
Build 887496124v1.12026-07-06 14:48:28

No pricing data captured yet — comparisons appear once the app has paid storefronts or in-app purchases.

Availability 61 of 61 storefronts

RegionLanguagePriceRatingsAvgVersion
AF en-GBFree0—1.2.1
AG en-GBFree0—1.2.1
AI en-GBFree0—1.2.1
BB en-GBFree0—1.2.1
BF en-GBFree0—1.2.1
BG en-GBFree0—1.2.1
BJ en-GBFree0—1.2.2
BY en-GBFree0—1.2.1
CA en-CAFree0—1.2.1
CD en-GBFree0—1.2.1
CG en-GBFree0—1.2.1
CI fr-FRFree0—1.2.1
CM fr-FRFree0—1.2.1
CO es-MXFree0—1.2.2
CV en-GBFree0—1.2.1
EE en-GBFree0—1.2.1
EG en-GBFree0—1.2.1
GA fr-FRFree0—1.2.1
GB en-GBFree0—1.2.1
GH en-GBFree0—1.2.2
GR en-GBFree0—1.2.1
HN es-MXFree0—1.3.0
HR en-GBFree0—1.2.1
IE en-GBFree0—1.2.1
JO en-GBFree0—1.2.1
KY en-GBFree0—1.2.1
LB en-GBFree0—1.2.1
LR en-GBFree0—1.2.1
LV en-GBFree0—1.2.1
LY en-GBFree0—1.2.2
MM en-GBFree0—1.2.1
MN en-GBFree0—1.2.1
MW en-GBFree0—1.2.1
MX es-MXFree0—1.2.1
NG en-GBFree0—1.2.2
NP en-GBFree0—1.2.1
NZ en-AUFree0—1.2.1
OM en-GBFree0—1.2.1
PA es-MXFree0—1.3.0
PE es-MXFree0—1.2.2
PG en-GBFree0—1.2.1
PK en-GBFree0—1.2.1
PY es-MXFree0—1.2.1
RU ruFree0—1.2.1
RW en-GBFree0—1.2.1
SB en-GBFree0—1.3.0
SC en-GBFree0—1.2.1
SE svFree0—1.2.1
SI en-GBFree0—1.2.1
SN en-GBFree0—1.2.1
SZ en-GBFree0—1.2.1
TO en-GBFree0—1.2.1
TZ en-GBFree0—1.2.2
UA en-GBFree0—1.2.1
UG en-GBFree0—1.2.1
US en-USFree0—1.3.0
UY en-GBFree0—1.2.1
VG en-GBFree0—1.3.0
YE en-GBFree0—1.2.1
ZM en-GBFree0—1.2.1
ZW en-GBFree0—1.2.1

Change log 15 changes · PG

◆
Version changed
1.2.1 → 1.3.0
◆
Version changed
1.2.1 → 1.3.0
✎
releaseNotes updated
Compare a whole drug class at once. Search a disease - like CML - and compare all its treatments side by side (for example, the six CML tyrosine kinase inhibito
▣
App icon changed
▣
Screenshots updated
◆
Version changed
1.2 → 1.3.0
◆
Version 1.3.0 released
Compare a whole drug class at once. Search a disease - like CML - and compare all its treatments side by side (for example, the six CML tyrosine kinase inhibitors), each with its FDA and EMA approval dates, drug class, and indication. Plus
◆
Version 1.2.2 released
• Fixed: some recently authorised EU medicines were missing from the Europe list (e.g. seladelpar/Lyvdelzi for PBC, zuranolone/Zurzuvae) • New: "Back to drug" button when jumping from a medicine to its Phase 3 trials • Fixed: view now scrol
◆
Version 1.2.1 released
Corrected wording in the Europe tab: medicines in the "Expected" list are now described as awaiting the European Commission decision, without implying the outcome of the CHMP opinion. The decision date shown remains an estimate.
✎
releaseNotes updated
NEW IN 1.2 • Home-screen widget — see the next expected EU decisions for the conditions you follow, at a glance. • Add to Calendar — export estimated EU decisi
✎
description updated
DrugRadar is a clean, fast tracker for newly approved pharmaceutical drugs and late-stage clinical trials, built on official public regulatory data. WHAT YOU C
✎
subtitle updated
FDA & EMA drug approvals
✎
name updated
DrugRadar
◆
Version 1.2 released
NEW IN 1.2 • Home-screen widget — see the next expected EU decisions for the conditions you follow, at a glance. • Add to Calendar — export estimated EU decision dates as calendar events, with a reminder three days ahead. • Saved searches
◆
Version 1.1 released
expanded screenshot